Related Experiment Video
Updated: Sep 10, 2025
11:15
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.0K
γδ T Cells in Glioblastoma Multiforme: Novel Roles and Therapeutic Opportunities
Costanza Dieli1,2, Rosario Maugeri3, Anna Maria Corsale1,4
1Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, 90133 Palermo, Italy.
Cancers
|August 28, 2025
Summary
Gamma delta (γδ) T cells show promise for treating glioblastoma (GBM), a highly aggressive brain cancer. Their unique properties offer new avenues for overcoming treatment resistance and improving patient outcomes.
Area of Science:
- Neuro-oncology
- Immunology
- Cancer Therapy
Background:
- Glioblastoma multiforme (GBM) presents significant therapeutic challenges due to its aggressive nature and immunosuppressive tumor microenvironment.
- Conventional treatments for GBM are often limited by tumor resistance and a hostile immune landscape.
- Gamma delta (γδ) T cells are being investigated for their potent antitumor capabilities and unique antigen recognition independent of HLA molecules.
Purpose of the Study:
- To review the multifaceted role of γδ T cells in the context of glioblastoma.
- To explore the mechanisms by which γδ T cells exert cytotoxic effects and interact with the GBM tumor microenvironment.
- To analyze factors influencing γδ T cell polarization and discuss strategies for enhancing their therapeutic efficacy in GBM.
Main Methods:
- Literature review focusing on preclinical studies and existing research on γδ T cells and glioblastoma.
- Analysis of γδ T cell functional plasticity, cytotoxic mechanisms, and interactions within the tumor microenvironment.
- Examination of factors influencing γδ T cell polarization and potential combination therapies.
Main Results:
- γδ T cells possess potent antitumor activity and can recognize tumor antigens without HLA restriction, making them suitable for GBM immunotherapy.
- Factors influencing γδ T cell polarization toward pro- or anti-tumor phenotypes within the GBM microenvironment were identified.
- Preclinical findings suggest that γδ T cells hold significant potential for GBM treatment.
Conclusions:
- γδ T cells represent a promising immunotherapeutic strategy for glioblastoma, offering a novel approach to combatting this aggressive cancer.
- Combinatorial strategies involving γδ T cell adoptive transfer, cytokine stimulation, and immune checkpoint inhibitors may enhance therapeutic outcomes.
- Further understanding of GBM-γδ T cell dynamics is crucial for developing innovative immunotherapies to overcome immune evasion and improve clinical results.
